rsv
furthermor
hmpv
major
contributor
burden
wintertim
respiratori
ill
older
adult
peak
incid
year
age
immunocompromis
individu
hmpv
infect
children
usual
mild
selflimit
elderli
immunocompromis
patient
clinic
cours
progress
acut
respiratori
distress
syndrom
ard
studi
patient
hmpv
develop
sever
ill
focus
children
involv
adult
nosocomi
infect
report
sever
studi
mode
transmiss
nosocomi
hmpv
infect
adult
occur
predominantli
human
immunodefici
virusinfect
person
studi
hmpv
infect
adult
korea
number
immunocompromis
patient
increas
hospit
patient
also
vulner
previous
neglect
pathogen
therefor
design
retrospect
review
hmpvinfect
adult
clinic
characterist
patientsinclud
demograph
data
comorbid
presenc
pneumonia
ard
acquisit
site
communityacquir
nosocomi
risk
factor
ardswer
review
studi
retrospect
review
medic
record
institut
review
board
approv
obtain
review
medic
record
patient
identifi
admit
intens
care
unit
icu
nosocomi
infect
met
criteria
ard
use
berlin
definit
incub
period
estim
day
nosocomi
infect
defin
infect
occur
day
discharg
day
admiss
death
inform
patient
confirm
use
hospit
medic
record
obliter
inform
nation
health
insur
servic
mean
death
clinic
relev
paramet
identifi
day
execut
mrtpcr
admiss
icu
ward
includ
temperatur
respiratori
rate
appli
fraction
inspir
oxygen
partial
pressur
arteri
oxygen
white
blood
cell
count
blood
urea
nitrogen
bun
creatinin
total
bilirubin
creactiv
protein
crp
level
procalcitonin
level
patient
divid
nonard
ard
group
risk
factor
laboratori
valu
ard
assess
data
analys
perform
use
spss
version
ibm
corp
armonk
ny
usa
categor
variabl
compar
fisher
exact
test
continu
variabl
wilcoxon
ranksum
test
impact
potenti
risk
factor
develop
ard
analyz
univari
logist
regress
analysi
statist
signific
variabl
univari
analysi
includ
multivari
logist
regress
analysi
backward
elimin
identifi
independ
risk
factor
ard
independ
influenc
risk
factor
ard
express
odd
ratio
confid
interv
signific
taken
p
mean
age
adult
patient
year
differ
accord
sex
tabl
overal
patient
viral
coinfect
bacteri
coinfect
coinfect
affect
event
ard
nosocomi
infect
mortal
patient
n
comorbid
includ
diabet
malign
pulmonari
diseas
cardiac
diseas
esrd
liver
cirrhosi
treat
corticosteroid
immuno
tabl
nonard
group
includ
patient
ard
group
includ
patient
mean
age
nonard
group
year
ard
group
year
p
howev
multivari
logist
regress
show
age
signific
tabl
pattern
viral
bacteri
coinfect
differ
ard
nonard
group
tabl
rate
comorbid
hmpvassoci
ard
patient
similar
hmpvassoci
ard
patient
except
congest
heart
failur
p
tabl
inhospit
allcaus
mortal
rate
ard
patient
respect
tabl
addit
analysi
show
kendal
rank
correal
coeffici
p
hospit
mortal
mortal
therefor
allcaus
mortal
independ
variabl
overal
patient
communityacquir
hmpv
infect
nosocomi
infect
patient
nosocomi
infect
show
presenc
comorbid
eg
solid
tumor
hematolog
disord
liver
cirrhosi
immunosuppress
therapi
p
howev
rate
mortal
hmpvassoci
ard
differ
communityacquir
nosocomi
infect
group
tabl
studi
first
character
ard
mortal
adult
patient
hmpv
infect
korea
although
scope
studi
necessari
focu
high
ard
incid
high
mortal
rate
increas
avail
broaden
scope
viral
respiratori
polymeras
chain
reaction
panel
help
understand
viral
pathogen
mrtpcr
assay
sensit
specif
higher
mrtpcr
could
detect
coinfect
respiratori
virus
even
low
viral
load
detect
use
cultur
techniqu
studi
period
peak
incid
hmpv
infect
april
influenza
peak
februari
studi
similar
area
conduct
report
peak
incid
hmpv
infect
januari
march
anoth
march
april
studi
subject
viral
coinfect
frequent
influenza
viru
tabl
agreement
previou
report
hmpv
infect
report
immunocompromis
patient
includ
lung
transplant
hematopoiet
stem
cell
transplant
recipi
moreov
outbreak
healthcar
facil
report
consid
implic
find
note
risk
nosocomi
hmpv
infect
rise
among
patient
blood
cancer
patient
solid
tumor
studi
multipl
limit
whether
hmpv
pathogen
patient
enrol
studi
unclear
howev
mrtpcr
assay
use
high
sensit
specif
also
rate
coinfect
pathogen
high
tabl
futur
studi
assess
clinic
featur
hmpv
infect
adult
determin
clinic
potenti
viru
respiratori
pathogen
induc
sever
ard
develop
novel
antivir
agent
vaccin
conclus
studi
suggest
hmpv
import
respiratori
pathogen
caus
pneumonia
ard
elderli
immunocompromis
individu
transmit
via
nosocomi
rout
clinician
need
consid
mmpv
viru
suffici
attent
requir
hyunjung
hwang
http
onlineonli
supplement
data
avail
articl
onlin
http
